Complement activation by heparin-protamine complexes during cardiopulmonary bypass: Effect of C4A null allele
- 30 September 1997
- journal article
- research article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 114 (3) , 482-488
- https://doi.org/10.1016/s0022-5223(97)70197-1
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Beneficial effects of duraflo II heparin-coated circuits on postperfusion lung dysfunctionThe Annals of Thoracic Surgery, 1996
- Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation.Journal of Clinical Investigation, 1995
- Complexes of a Modified Low-Molecular-Weight Heparin with Protamine Are Predominantly Cleared by a Macrophage Scavenger Receptor-Mediated Process in RatsJournal of Surgical Research, 1995
- Association of Protamine IgE and IgG Antibodies with Life-Threatening Reactions to Intravenous ProtamineNew England Journal of Medicine, 1989
- Monoclonal rheumatoid factor–igg immune complexes. poor fixation of opsonic c4 and c3 despite efficient complement activationArthritis & Rheumatism, 1988
- Effects of Protamine Administration after Cardiopulmonary Bypass on Complement, Blood Elements, and the Hemodynamic StateThe Annals of Thoracic Surgery, 1986
- Phagocytosis of Protamine—heparin aggregates by mouse peritoneal exudate cellsFolia Microbiologica, 1985
- Complement Activation during Cardiopulmonary BypassNew England Journal of Medicine, 1981
- Inherited structural polymorphism of the fourth component of human complement.Proceedings of the National Academy of Sciences, 1980
- Genetic polymorphism of human complement C4 and detection of heterozygotesNature, 1979